Arvind Chaudhry
Impact in
Papers in
- Oncology 22
- Cancer Immunotherapy and Biomarkers 10
- HER2/EGFR in Cancer Research 7
- CAR-T cell therapy research 6
- Co-authors
- Keiko Funa (3 shared papers)Kjell Öberg (2 shared papers)C H Heldin (1 shared paper)Carl‐Henrik Heldin (1 shared paper)Anders Gobl (1 shared paper)Frank R. Jones (3 shared papers)Younong Xu (3 shared papers)Elizabeth S. Gabitzsch (3 shared papers)
- Journals
- Journal of Clinical Oncology (18 papers)Annals of Oncology (5 papers)Blood (3 papers)Journal for ImmunoTherapy of Cancer (2 papers)Cancer Immunology Immunotherapy (2 papers)
- Partner nations
- United StatesChinaPoland
In The Last Decade
Arvind Chaudhry
45 papers receiving 710 citations
Peers
Comparison fields: 5 of 59
- Oncology 398
- Neurology 115
- Epidemiology 234
- Immunology 132
- Physiology 24
Countries citing papers authored by Arvind Chaudhry
This map shows the geographic impact of Arvind Chaudhry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arvind Chaudhry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arvind Chaudhry more than expected).
Fields of papers citing papers by Arvind Chaudhry
This network shows the impact of papers produced by Arvind Chaudhry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arvind Chaudhry. The network helps show where Arvind Chaudhry may publish in the future.
Co-authors
The 25 scholars most cited alongside Arvind Chaudhry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Expression of platelet-derived growth factor and its receptors in neuroendocrine tumors of the digestive system. | 1992 | 105 |
| 2 | 1993 | 103 | |
| 3 | 2013 | 73 | |
| 4 | Expression of transforming growth factors beta 1, beta 2, beta 3 in neuroendocrine tumors of the digestive system. | 1995 | 65 |
| 5 | Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer. | 1999 | 56 |
| 6 | Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors. | 1994 | 40 |
| 7 | 2015 | 39 | |
| 8 | 2016 | 38 | |
| 9 | 2022 | 30 | |
| 10 | 2019 | 28 | |
| 11 | 2024 | 17 | |
| 12 | 2021 | 11 | |
| 13 | 2020 | 11 | |
| 14 | 1996 | 10 | |
| 15 | 2021 | 9 | |
| 16 | 2020 | 9 | |
| 17 | 2023 | 8 | |
| 18 | 2021 | 7 | |
| 19 | 2021 | 7 | |
| 20 | 2023 | 7 |
About Arvind Chaudhry
Arvind Chaudhry is a scholar working on Oncology, Molecular Biology, Genetics, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 48 papers that have together received 737 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Chronic Lymphocytic Leukemia Research (9 papers), HER2/EGFR in Cancer Research (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), CAR-T cell therapy research (6 papers), Immunotherapy and Immune Responses (6 papers), Neuroendocrine Tumor Research Advances (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Oncology (398 citations), Neurology (115 citations), Epidemiology (234 citations), Immunology (132 citations) and Physiology (24 citations). Arvind Chaudhry has collaborated with scholars based in United States, China and Poland. Frequent co-authors include Keiko Funa, Kjell Öberg, C H Heldin, Carl‐Henrik Heldin, Anders Gobl, Frank R. Jones, Younong Xu, Elizabeth S. Gabitzsch, Michael A. Morse and Joseph P. Balint. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Blood, Journal for ImmunoTherapy of Cancer and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.